Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor.

Oncotarget · 2015 · PMC4745700 · PMID 26359629

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, the benefits of using C4opt-27z RNA CAR T cells against solid tumor, while highly significant, were less dramatic and mimic those reported with HER-2/ErbB2-specific RNA CAR T cells against solid ovarian cancer [ 43 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.